Updated technical guidelines by the European Centre for Disease Prevention and Control (ECDC) will help prevent the transmission of hepatitis B virus (HBV) and hepatitis C virus (HCV) through substances of human origin, including donated blood, stem cells, reproductive cells, and tissue, and establish a single, EU-wide standard for patient safety during medical procedures.
Source: European Centre for Disease Prevention and Control (ECDC)
European Centre for Disease Prevention and Control (ECDC)
- Ebola disease outbreak in the Democratic Republic of the Congo and Uganda
- World Mosquito Day 2026: Europe must upgrade control tools as disease risks rise
- Epidemiological update – 11 August 2026: Imported case of Andes hantavirus in the EU/EEA
- Surveillance of Mpox in the EU/EEA, monthly report
- Chikungunya virus disease worldwide overview
- As sustained heatwaves increase the risk of infectious diseases across Europe, ECDC scales up action and calls for cooperation
- World Hepatitis Day 2026: Ensuring that life-saving interventions are accessible to everyone who needs them is a common challenge
- World Hepatitis Day 2026: Despite progress towards eliminating hepatitis in Europe, gaps in prevention measures keep 2030 targets out of reach
- New guidance launched to help Europe detect respiratory virus threats earlier
- Drug-resistant gonorrhoea on the rise in Europe, ECDC warns
